Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency

Equality Impact Assessment (Guidance development) (PDF 149 KB)

Final draft guidance

Public committee slides (PDF 1.35 MB)

Committee papers (PDF 9.29 MB)

Final appraisal document (PDF 228 KB)

Final stakeholder list (PDF 189 KB)

Final scope (PDF 219 KB)

Equality Impact Assessment (Guidance development) (PDF 122 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 247 KB)

Draft matrix post referral (PDF 191 KB)

Draft scope post referral (PDF 257 KB)

Draft scope post referral (PDF 375 KB)

Draft matrix post referral (PDF 264 KB)